Dr. Peter Reaven, MD
Claim this profilePhoenix VA Health Care System, Phoenix, AZ
Studies Atherosclerosis
Studies Prediabetes
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
Clinical Trials Peter Reaven, MD is currently running
More about Peter Reaven, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Peter Reaven, MD has experience with
- Metformin XR
- Placebo
Breakdown of trials Peter Reaven, MD has run
Atherosclerosis
Prediabetes
Metformin
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Reaven, MD specialize in?
Peter Reaven, MD focuses on Atherosclerosis and Prediabetes. In particular, much of their work with Atherosclerosis has involved treating patients, or patients who are undergoing treatment.
Is Peter Reaven, MD currently recruiting for clinical trials?
Yes, Peter Reaven, MD is currently recruiting for 1 clinical trial in Phoenix Arizona. If you're interested in participating, you should apply.
Are there any treatments that Peter Reaven, MD has studied deeply?
Yes, Peter Reaven, MD has studied treatments such as Metformin XR, Placebo.
What is the best way to schedule an appointment with Peter Reaven, MD?
Apply for one of the trials that Peter Reaven, MD is conducting.
What is the office address of Peter Reaven, MD?
The office of Peter Reaven, MD is located at: Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona 85012 United States. This is the address for their practice at the Phoenix VA Health Care System, Phoenix, AZ.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.